← Back to Search

Voxx Socks for Chemotherapy-Induced Peripheral Neuropathy

N/A

Recruiting

Research Sponsored by Arash Asher, MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years

Self-reported average neuropathic pain score of at least 4 on a 10-point scale over the past 1 month

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks

Awards & highlights

Study Summary

This trial will test whether or not a new type of sock can help reduce chemotherapy-induced peripheral neuropathy, a condition that causes tingling, numbness, and pain in the hands and feet.

Who is the study for?

This trial is for adults over 18 who have had cancer and completed certain chemotherapy treatments at least three months ago. They must be experiencing neuropathy from the chemo, not other causes like diabetes or alcohol, and can't be in another neuropathy study.Check my eligibility

What is being tested?

The study tests Voxx Human Performance Technology Socks against placebo socks to see if they help with nerve pain caused by chemo. Participants wear one type of sock for two weeks, then switch after a break period, while their symptoms are monitored.See study design

What are the potential side effects?

Since this trial involves wearing special socks versus placebo socks, there are no direct medicinal side effects expected. However, any discomfort or skin reactions related to sock use will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My average nerve pain score has been 4 or more in the last month.

Select...

My cancer is between stage 1 and stage 4.

Select...

I have nerve pain or numbness from chemotherapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in subjective measurement of chemotherapy-induced peripheral neuropathy

Secondary outcome measures

Malignant Neoplasms

Change in objective measurement of chemotherapy-induced peripheral neuropathy (score on the Modified Total Neuropathy Scale)

Change in objective measurement of chemotherapy-induced peripheral neuropathy (score on the Timed Up and Go test)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm B: Placebo socks followed by Voxx socksExperimental Treatment2 Interventions

Continuous wear of placebo socks for 2 weeks, followed by continuous wear of Voxx Human Performance Technology Socks for 2 weeks (separated by a 2-week washout period)

Group II: Arm A: Voxx socks followed by placebo socksExperimental Treatment2 Interventions

Continuous wear of Voxx Human Performance Technology Socks for 2 weeks, followed by continuous wear of placebo socks for 2 weeks (separated by a 2-week washout period)

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

Arash Asher, MDLead Sponsor

3 Previous Clinical Trials

49 Total Patients Enrolled

VoxxLifeUNKNOWN

Media Library

Voxx Human Performance Technology Socks Clinical Trial Eligibility Overview. Trial Name: NCT04403802 — N/A

Peripheral Neuropathy Research Study Groups: Arm B: Placebo socks followed by Voxx socks, Arm A: Voxx socks followed by placebo socks

Peripheral Neuropathy Clinical Trial 2023: Voxx Human Performance Technology Socks Highlights & Side Effects. Trial Name: NCT04403802 — N/A

Voxx Human Performance Technology Socks 2023 Treatment Timeline for Medical Study. Trial Name: NCT04403802 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant slots for participants in this research?

"According to the research shared on clinicaltrials.gov, this medical trial is currently looking for volunteers. This experiment was initially advertised on October 16th 2020 and had its latest update posted September 19th 2022."

Answered by AI

What is the sample size of this clinical trial?

"Affirmative. According to information provided on clinicaltrials.gov, the research is actively sourcing individuals for participation. This investigation was first put up on October 16th 2020 and it has been modified most recently on September 19th 2022. The trial requires 30 participants across a single medical establishment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy

Arash Asher, MD 2020. "Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04403802.

All > Neuropathy > Peripheral Neuropathy